Now showing items 1-4 of 4

    • Safe, Stephen H.; Chintharlapalli, Sudhakar; Mcalees, Alan; Mccrindle, Robert (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2013-03-05)
      The present invention relates to novel derivatives of glycyrrhetinic acid, compositions comprising said derivatives and their use in the treatment of conditions or diseases that benefit from an upregulation of PPAR&ggr ...
    • Carney, Darrell H.; Olszewska-pazdrak, Barbara; Fossum, Theresa W. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2012-12-18)
      Endothelial dysfunction (ED) is associated with a number of diseases and disorders. Agonists of the non-proteolytically activated thrombin receptor can be used in methods to treat ED or ED-related diseases and disorders.
    • Reddy, Doodipala Samba (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2019-01-08)
      The present invention provides new compositions and methods for treating and/or reversing organophosphate intoxication, manifested by both cholinergic and non-cholinergic crisis, in a mammal resulting from exposure to ...
    • Tjalkens, Ronald B.; Safe, Stephen (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2013-11-12)
      Presented herein are diindolylmethane derivative compounds useful for the prevention and or treatment of neurological conditions, including neurological conditions related to neuroinflammation. One such neurological condition ...